These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16791016)

  • 1. Grey nails predict low CD4 cell count among untreated patients with HIV infection in Malawi.
    Scarborough M; Gordon SB; French N; Phiri C; Musaya J; Zijlstra EE
    AIDS; 2006 Jun; 20(10):1415-7. PubMed ID: 16791016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
    Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R;
    HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia.
    Madec Y; Laureillard D; Pinoges L; Fernandez M; Prak N; Ngeth C; Moeung S; Song S; Balkan S; Ferradini L; Quillet C; Fontanet A
    AIDS; 2007 Jan; 21(3):351-9. PubMed ID: 17255742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
    Bwire R; Nagelkerke NJ; Borgdorff MW
    Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiating antiretroviral treatment in a resource-constrained setting: does clinical staging effectively identify patients in need?
    Torpey K; Lartey M; Amenyah R; Addo NA; Obeng-Baah J; Rahman Y; Suzuki C; Mukadi YD; Colebunders R
    Int J STD AIDS; 2009 Jun; 20(6):395-8. PubMed ID: 19451324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of serum albumin in pretreatment assessment and monitoring of therapy in HIV/AIDS patients.
    Olawumi HO; Olatunji PO
    HIV Med; 2006 Sep; 7(6):351-5. PubMed ID: 16903978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting CD4 testing to a clinical subgroup of patients could limit unnecessary CD4 measurements, premature antiretroviral treatment and costs in Thyolo District, Malawi.
    Zachariah R; Teck R; Ascurra O; Humblet P; Harries AD
    Trans R Soc Trop Med Hyg; 2006 Jan; 100(1):24-31. PubMed ID: 16202436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.
    Ruiz L; Paredes R; Gómez G; Romeu J; Domingo P; Pérez-Alvarez N; Tambussi G; Llibre JM; Martínez-Picado J; Vidal F; Fumaz CR; Clotet B;
    AIDS; 2007 Jan; 21(2):169-78. PubMed ID: 17197807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of nail and oral pigmentation to determine ART eligibility among HIV-infected Ugandan adults.
    Namakoola I; Wakeham K; Parkes-Ratanshi R; Levin J; Mugagga T; Seymour C; Kissa J; Kamali A; Lalloo DG
    Trop Med Int Health; 2010 Feb; 15(2):259-62. PubMed ID: 20409288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy.
    Huttner AC; Kaufmann GR; Battegay M; Weber R; Opravil M
    AIDS; 2007 May; 21(8):939-46. PubMed ID: 17457087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
    Ho C; Lee S; Wong Kh; Cheng L; Lam M
    HIV Med; 2007 Apr; 8(3):181-5. PubMed ID: 17461862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.
    Bisson GP; Gross R; Strom JB; Rollins C; Bellamy S; Weinstein R; Friedman H; Dickinson D; Frank I; Strom BL; Gaolathe T; Ndwapi N
    AIDS; 2006 Aug; 20(12):1613-9. PubMed ID: 16868442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
    J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy.
    D'Orsogna LJ; Krueger RG; McKinnon EJ; French MA
    AIDS; 2007 Aug; 21(13):1747-52. PubMed ID: 17690573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
    ter Horst R; Collin SM; Ritmeijer K; Bogale A; Davidson RN
    Clin Infect Dis; 2008 Jun; 46(11):1702-9. PubMed ID: 18419422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression.
    Nnoruka EN; Chukwuka JC; Anisuiba B
    Int J Dermatol; 2007 Oct; 46 Suppl 2():14-8. PubMed ID: 17958624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study.
    Wolbers M; Bucher HC; Furrer H; Rickenbach M; Cavassini M; Weber R; Schmid P; Bernasconi E; Hirschel B; Battegay M;
    HIV Med; 2008 Jul; 9(6):397-405. PubMed ID: 18410354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.